top of page

Feng Lin, PhD

Research Scientist
Stemcell Biology and Immunology

  • LinkedIn
Feng Bio


Dr. Feng Lin has 17 years of experience in the fields of immunotherapy and cell therapy. His journey has been marked by leadership roles in new product development and commercial functions within prominent biotech companies.

Having led diverse teams, Dr. Lin has played a crucial role in the development of antibody drugs and immune cell therapies, both in preclinical and clinical settings. His approach reflects a commitment to advancing therapeutic interventions and contributing to the forefront of biomedical research.

Dr. Lin's academic foundation was established at the Central South University Xiang-Ya School of Medicine in Changsha, China, where he earned a Ph.D. in Hematology and Physiology. Complementing this, he holds an M.Sc. in Biochemistry and Molecular Biology and an M.D. in Medicine.​

Most Recent Publications

1. Lin F, Lin EZ, Anekoji M, Ichim TE, Hu J, Marincola FM, Jones LD, Kesari S, Ashili S. Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines. Journal of Translational Medicine, 2023, accepted for publication.

2. Perez JA, Parcero Valdes JJ, Moreno RC, Gomez Cuevas LI, Lopez JJ, Ichim T, McGreevy K, Lin F, Kesari S, Souvik Datta. Intravenous administration of umbilical cord-derived mesenchymal stem cell (UC-MSC) for acute respiratory distress syndrome due to COVID-19 infection. Cureus, 2023, 15(8): e44110. DOI 10.7759/cureus.44110.

3. Pingle SC, Lin F, Anekoji MS, Kesari S, and Ashili S. Exploring the role of cerebrospinal fluid as analyte in neurologic disorders. Future Science OA, 2023, 10.2144/fsoa-2023-0006

4. Datta S, Lin F, Jones LD, Pingle SC, Kesari S, Ashili S. Traumatic brain injury and immunological outcomes: the double-edged killer. Future Science OA, 2023, 10.2144/fsoa-2023-0037

5. K. Patro CP, Biswas N, Pingle SC , Lin F, Anekoji M, Jones LD, Kesari S, Wang F, Ashili S. MTAP loss: a possible therapeutic approach for glioblastoma. Journal of Translational Medicine, 2022, 20:620

6. Sunny JS, K Patro CP, Khushi K, Pingle SC, Lin F, Anekoji M,  Jones LD, Kesari S and Ashili S. Anomaly detection framework for wearables data: a perspective review on data concepts, data analysis algorithms and prospects. Sensors (Basel), 2022, 22:756(1-18) 

7. Lin F, Anekoji M, Ichim TE, et al. Immunotherapeutic peptide vaccine approaches to glioma. Journal of Cancer Research Reviews & Reports, 2021, 3:1-11 

8. Lin F, Ichim TE, Pingle S, Jones LD, Kesari S, Ashili S. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome. 2020, 12:1067-1079

9. Lin F, Josephs SF, Alexadrescu DT, Ramos F, Bogin V, Gammill V, Dasanu CA, De Necochea-Campion R, Patel AN, Carrier E, Koos DR. Laser, stem cells, and COPD. J Transl Med. 2010, 8:16. doi: 10.1186/1479-5876-8-16. 

10. Broderick KE, Chan A, Lin F, Shen X, Kichaev G, Khan AS, Aubin J, Zimmermann TS, Sardesai NY. Optimized in vivo transfer of small interfering RNA targeting dermal tissue using in vivo surface electroporation. Molecular Therapy- Nucleic Acids. 2012 Feb 14; 1:e11
bottom of page